PNC FINANCIAL SERVICES GROUP, INC. - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 254 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.

Quarter-by-quarter ownership
PNC FINANCIAL SERVICES GROUP, INC. ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$61,695
-92.4%
2,296
-89.9%
0.00%
-100.0%
Q2 2023$814,190
+48.0%
22,832
+5.4%
0.00%
Q1 2023$549,986
-40.6%
21,653
-5.1%
0.00%
-100.0%
Q4 2022$925,335
+19.7%
22,814
-2.5%
0.00%0.0%
Q3 2022$773,000
-1.4%
23,399
+5.1%
0.00%0.0%
Q2 2022$784,000
-24.8%
22,254
-1.9%
0.00%0.0%
Q1 2022$1,043,000
-30.8%
22,684
-0.2%
0.00%0.0%
Q4 2021$1,507,000
+8.3%
22,727
+1.9%
0.00%0.0%
Q3 2021$1,392,000
-25.8%
22,295
-1.6%
0.00%
-50.0%
Q2 2021$1,876,000
+25.2%
22,649
+0.2%
0.00%
+100.0%
Q1 2021$1,499,000
-13.1%
22,614
+0.7%
0.00%
-50.0%
Q4 2020$1,724,000
+86.4%
22,458
+4.5%
0.00%
+100.0%
Q3 2020$925,000
+963.2%
21,495
+969.4%
0.00%
Q2 2020$87,000
+42.6%
2,010
-5.6%
0.00%
Q1 2020$61,000
-60.1%
2,130
-11.3%
0.00%
Q4 2019$153,000
+61.1%
2,402
-28.7%
0.00%
Q3 2019$95,000
+28.4%
3,369
+20.3%
0.00%
Q2 2019$74,000
+825.0%
2,801
+600.2%
0.00%
Q3 2018$8,000
+300.0%
400
+36.1%
0.00%
Q2 2016$2,0002940.00%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q3 2023
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 908,474$24,410,69622.12%
Western Financial Corp/CA 820,239$22,039,82216.16%
JOHNSON & JOHNSON 247,598$6,652,9582.45%
WEALTH EFFECTS LLC 164,750$4,426,8352.19%
M28 Capital Management LP 67,400$1,811,0382.08%
Privium Fund Management B.V. 259,036$6,960,2982.07%
Evolutionary Tree Capital Management, LLC 51,266$1,377,5171.78%
Avidity Partners Management LP 1,063,897$28,586,9121.15%
SECTORAL ASSET MANAGEMENT INC 157,552$4,233,4220.82%
Vivo Capital, LLC 137,411$3,692,2340.40%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders